These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12704537)

  • 1. Matrix metalloproteinase-9 and urokinase-type plasminogen activator in varicose veins.
    Kosugi I; Urayama H; Kasashima F; Ohtake H; Watanabe Y
    Ann Vasc Surg; 2003 May; 17(3):234-8. PubMed ID: 12704537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC; Yao JS
    J Vasc Surg; 1996 Nov; 24(5):719-24. PubMed ID: 8918314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13.
    Gillespie DL; Patel A; Fileta B; Chang A; Barnes S; Flagg A; Kidwell M; Villavicencio JL; Rich NM
    J Surg Res; 2002 Aug; 106(2):233-8. PubMed ID: 12175972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of lymphatic vessels and regional lipid accumulation is associated with great saphenous vein incompetence.
    Tanaka H; Zaima N; Sasaki T; Yamamoto N; Sano M; Konno H; Setou M; Unno N
    J Vasc Surg; 2012 May; 55(5):1440-8. PubMed ID: 22226181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.
    Nomura S; Yoshimura K; Akiyama N; Mikamo A; Furutani A; Aoki H; Matsuzaki M; Hamano K
    Eur Surg Res; 2005; 37(6):370-8. PubMed ID: 16465063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro differences between smooth muscle cells derived from varicose veins and normal veins.
    Xiao Y; Huang Z; Yin H; Lin Y; Wang S
    J Vasc Surg; 2009 Nov; 50(5):1149-54. PubMed ID: 19703751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
    Asahina M; Yoshiyama Y; Hattori T
    Clin Neuropathol; 2001; 20(2):60-3. PubMed ID: 11327298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
    Saito S; Zempo N; Yamashita A; Takenaka H; Fujioka K; Esato K
    Vasc Endovascular Surg; 2002; 36(1):1-7. PubMed ID: 12704518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study.
    Xu N; Zhang YY; Lin Y; Bao B; Zheng L; Shi GP; Liu J
    Thromb Haemost; 2014 Feb; 111(2):333-44. PubMed ID: 24154706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase expression in venous aneurysms.
    Irwin C; Synn A; Kraiss L; Zhang Q; Griffen MM; Hunter GC
    J Vasc Surg; 2008 Nov; 48(5):1278-85. PubMed ID: 18971037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes?
    Sansilvestri-Morel P; Fioretti F; Rupin A; Senni K; Fabiani JN; Godeau G; Verbeuren TJ
    Clin Sci (Lond); 2007 Feb; 112(4):229-39. PubMed ID: 17020541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3.
    Sansilvestri-Morel P; Rupin A; Jullien ND; Lembrez N; Mestries-Dubois P; Fabiani JN; Verbeuren TJ
    J Vasc Res; 2005; 42(5):388-98. PubMed ID: 16088212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovascularization: an "innocent bystander" in recurrent varicose veins.
    Egan B; Donnelly M; Bresnihan M; Tierney S; Feeley M
    J Vasc Surg; 2006 Dec; 44(6):1279-84; discussion 1284. PubMed ID: 17145430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the gene expression of CLOCK is correlated with hypoxia-inducible factor 1α in advanced varicose lesions.
    Tang X; Guo D; Lin C; Shi Z; Qian R; Fu W; Liu J; Li X; Fan L
    Mol Med Rep; 2015 Oct; 12(4):6164-70. PubMed ID: 26299356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of saphenous reflux in women with primary varicose veins.
    Engelhorn CA; Engelhorn AL; Cassou MF; Salles-Cunha SX
    J Vasc Surg; 2005 Apr; 41(4):645-51. PubMed ID: 15874929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role for relaxin-2 in the pathogenesis of primary varicosis.
    Adams J; Schott S; Bern A; Renz M; Ikenberg K; Garbe C; Busch C
    PLoS One; 2012; 7(6):e39021. PubMed ID: 22737225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.